TPG GP A, LLC
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 14, 2025), TPG GP A, LLC reported 9 stock positions worth $1.8 billion. Its top holding was Lifestance Health (LFST) at 48.1% of the portfolio, followed by Life Time (LTH, 26.8%) and Sionna Therapeutics (SION, 10.8%). Compared with Q2 2025, it reduced 2. The biggest sale was Life Time (LTH, shares −17%).
- Most Recent 13F
- Q2 2026
- Location
- FORT WORTH, TX
- CIK
- 0001903793
- Portfolio Value
- $1.8B (Q3 2025)
- SEC Filing
- 0001999371-25-017885 ↗ filed Nov 14, 2025
Holdings Value
Holdings 9 stocks · $1.8B
| LFST Lifestance Health Group Inc. | 48.14% | 160,711,618 | $883.9M | No change |
| LTH Life Time Group Holdings Inc. | 26.80% | 17,830,652 | $492.1M | Reduce -16.7% |
| SION Sionna Therapeutics Inc. | 10.80% | 6,744,962 | $198.4M | No change |
| AMRX Amneal Pharmaceuticals Inc. | 6.72% | 12,328,767 | $123.4M | No change |
| BCAX Bicara Therapeutics Inc. | 2.59% | 3,010,425 | $47.5M | No change |
| CBLL Ceribell Inc. | 2.48% | 3,967,422 | $45.6M | No change |
| ALLO Allogene Therapeutics Inc. | 1.26% | 18,716,306 | $23.2M | No change |
| TRTX TPG Re Finance Trust Inc. | 1.12% | 2,392,863 | $20.5M | Reduce -66.2% |
| RLYB Rallybio Corp. | 0.08% | 3,028,414 | $1.5M | No change |
Portfolio Sells Q2 2025 → Q3 2025
Portfolio Buys Q2 2025 → Q3 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 56 | $4.7B | LFST, SPCX, JXN, LTH, SION |
| Q1 2026 | 49 | $3.4B | LFST, JXN, LTH, SION, BETA |
| Q4 2025 | 10 | $2.7B | LFST, LTH, BETA, SION, AMRX |
| Q3 2025 | 9 | $1.8B | LFST, LTH, SION, AMRX, BCAX |
| Q2 2025 | 9 | $1.9B | LFST, LTH, SION, AMRX, CBLL |
| Q1 2025 | 27 | $5.0B | LFST, LTH, VIK, TTAN, PEGA |
| Q4 2024 | 31 | $6.2B | VIK, LFST, LTH, TTAN, MTN |
| Q3 2024 | 35 | $5.9B | VIK, LFST, LTH, PGRU, UNH |
| Q2 2024Amended | 34 | $6.4B | VIK, LTH, LFST, LW, PGRU |
| Q1 2024Amended | 34 | $5.2B | LFST, LTH, Nextracker Inc, Progyny Inc, ELV |